Journal of Peking University(Health Sciences) ›› 2015, Vol. 47 ›› Issue (4): 597-600. doi: 10.3969/j.issn.1671-167X.2015.04.009

• Articles • Previous Articles     Next Articles

Efficacy and outcome of palliative TURP in patients with bladder outlet obstruction induced by advanced prostate cancer

LIU Lei, HOU Xiao-fei△, MA Lu-lin, ZHAO Lei, ZHANG Hong-xian   

  1. (Department of Urology, Peking University Third Hospital, Beijing 100191, China)
  • Online:2015-08-18 Published:2015-08-18
  • Contact: HOU Xiao-fei E-mail:houxf12@163.com

Abstract:

Objective: To evaluate the efficacy and outcome of palliative transurethral resection of the prostate (pTURP) in patients with server bladder outlet obstruction (BOO) due to prostatic obstruction induced by advanced prostate cancer.Methods:All the 16 patients who had a pTURP between November 2007 and January 2015 due to BOO (high residual urine volume combined with hydronephrosis or urinary retention refractory to medical treatment ) at our institution were retrospectively assessed. All the patients were diagnosed with advanced prostate cancer (Ⅲ stage or Ⅳ stage). The clinical data, functional and oncological follow-up results were evaluated. The cancer specific survivals were estimated by Kaplan-Meier analysis.Results:The mean age of the patients was 73.8 years (63-81 years). Five  cases were graded in stage Ⅲ of prostate cancer and 11  in stage Ⅳ. The indications for pTURP were refractory urinary retention in 12 cases, and high residual urine volume with hydronephrosis in 4 cases. The mean prostate volume at pTURP was 43.2 mL (28-78 mL) and the mean PSA (prostate specific antigen) level before pTURP was 48.2 μg/L (2-107 μg/L). The patients had mean residual urine volume 166.4 mL (50-450 mL) and mean urinary flow rate 3.6 mL/s(0-6 mL/s, n=7) before pTURP. It took mean 62.9min (35-94 min) in pTURP with mean estimated blood loss 126.9 mL (30-263 mL) and mean resected tissue 14.1 g (10-22 g). There were no transfusion cases. Postoperative mean serum PSA 20.5 μg/L (1-41 μg/L), residual urine volume 43.4 mL (0-400 mL) and urinary flow rate 10.1 mL/s (7-16 mL/s, n=7) were shown in these cases. A patient encountered persistent hematuria needing irrigation. Compared with preoperation, the patients had significantly lower serum PSA level (P<0.001), less residual urine volume (P<0.001) and more urinary flow rate (P=0.001) after pTURP. The mean follow-up after pTURP was 36 months (1-86 months). In addition, 2 patients received repeated pTURP. At the time of the latest analysis, 3 patients died from prostate cancer progression. As estimated by KaplanMeier analysis, the 2-, 3- and 5-year cancer specific survival rates after pTURP were 91%, 78% and 58%, respectively.Conclusion:Despite less resected tissue, greater delay in urination and reoperation rates, pTURP is a fairly effective procedure in patients with server BOO . Although a potential negative impact of pTURP on survival cannot be excluded, the estimated 3 and 5year cancer specific survival rates in this series seem to justify this intervention.

Key words: Prostatic neoplasms, Urinary bladder neck obstruction, Transurethral resection of prostate

CLC Number: 

  • R737.25
[1] Yi-chang HAO,Ye YAN,Fan ZHANG,Min QIU,Lang ZHOU,Ke LIU,Jian LU,Chun-lei XIAO,Yi HUANG,Cheng LIU,Lu-lin MA. Surgical strategy selection and experience summary of prostate cancer with positive single needle biopsy [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 625-631.
[2] Yi LIU,Zhi-jian LIU,Qi SHEN,Jing-yun WU,Yu FAN,De-run LI,Wei YU,Zhi-song HE. A clinical analysis of 14 cases of prostatic stromal tumor of uncertain malignant potential [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 621-624.
[3] Ye YAN,Hai-zhui XIA,Xu-sheng LI,Wei HE,Xue-hua ZHU,Zhi-ying ZHANG,Chun-lei XIAO,Yu-qing LIU,Hua HUANG,Liang-hua HE,Jian LU. Application of U-shaped convolutional neural network in auto segmentation and reconstruction of 3D prostate model in laparoscopic prostatectomy navigation [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 596-601.
[4] ZHANG Fan, XIAO Chun-lei, ZHANG Shu-dong, HUANG Yi, MA Lu-lin. Relationship between recovery of urinary continence after laparoscopic radical prostatectomy and prostatic volume and intravesical prostatic protursion length [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 621-625.
[5] BI Yong-xiang, XIAO Min-hui, ZHANG Ning-nan, LI Xiao-yun, MAO Xiao-peng, ZHANG Ke, ZHANG Zhuo-rui, ZHAO Liang-yun. Construction and improvement of animal models with different positional osseous metastasis of prostate cancer in vivo [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 590-596.
[6] LIU Zhuo, LUO Cheng, HU Shuai, FAN Yu, LIU Zhen-hua, YANG Xin-yu, SHEN Qi, LIU Li-bo, HAN Wen-ke, ZHOU Li-qun, YU Wei, HE Qun, ZHANG Qian, JIN Jie. Diagnosis and treatment of T1a-T1b prostate cancer [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 812-816.
[7] WANG Gong-wei, SHEN Dan-hua, ZHANG Wei-Yu, XU Ke-xin, XU Tao, HU Hao. Trends in Gleason scores of Chinese prostate carcinoma from 1995 to 2014 [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 801-805.
[8] LIU Zhuo, MA Lu-lin, ZHANG Shu-dong, LU Min, TIAN Yu, HE Qun, JIN Jie. Basal cell carcinoma of prostate: a report of three cases [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 720-724.
[9] ZUO Qiang, ZHANG Fan, HUANG Yi, MA Lu-lin, LU Min, LU Jian. Clinically predictive factors of Gleason score upgrading in patients after radical prostatectomy [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 603-606.
[10] HU Feng-zhan, YUAN Wan-qiong, WANG Xiao-lin, QIN Cai-peng, SHENG Zheng-zuo, DU Yi-qing, YIN Hua-qi, XU Tao. Knockdown of CMTM3 promotes migration and invasion of PC3 cell in vitro [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 594-597.
[11] ZHANG Feng-Bo, DU Yuan, SHAO Qiang, TIAN Ye. Treatment of local low/intermediate risk prostate cancer with low dose rate brachytherapy: a report of 133 cases at a single center [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 611-614.
[12] YANG Kai-Wei, YU Wei, SONG Yi, HUANG Li-Hua, HAN Wen-Ke, HE Zhi-Song, JIN Jie, ZHOU Li-Qun. Predictor analysis of PSA response of docetaxel combined with prednisone in the treatment of metastatic castration resistant prostate cancer [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 592-596.
[13] FAN Yu, Liu-Zhuo, Zhang-Lian, Li-De-Run, He-Qun, Yang-Xin-Yu, Shen-Qi, Hu-Shuai, Liu-Li-Bo, Shan-Gang-Zhi, Li-Shu-Qing, Meng-Yi-Sen, Wang-Yu, Yu-Wei, Zhang-Qian, He-Zhi-Song, Zhou-Li-Qun, Jin-Jie. A head-to-head comparison of contemporary indolent prostate cancer screen protocols in Chinese [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 586-591.
[14] YUAN Ye-Qing, ZHANG Yi-Xiang, LIU Zhen-Hua, QIN Cai-Peng, SHENG Zheng-Zuo, XU Tao, WANG Xiao-Feng. Expression and significance of CMTM5 and epidermal growth factor receptor in prostate cancer [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 571-576.
[15] MA Hong, ZHU Gang, WAN Ben, WU Peng-Jie, WANG Jian-Ye. Use of abiraterone acetate in the treatment of patients with metastatic castration resistant prostate cancer and no prior chemotherapy: 3 case reports and literature review [J]. Journal of Peking University(Health Sciences), 2014, 46(4): 653-656.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .